Leadership changes reinforce IDDI’s commitment to scientific excellence, strategic innovation, and customer experience
BRUSSELS; RALEIGH, N.C.; 10 September 2026 – IDDI, the premier clinical data science partner, today announced the appointment of Maud Larochette as Chief Executive Officer (CEO), succeeding IDDI founder Marc Buyse, ScD.
Maud brings extensive leadership and transformation experience, with a track record of helping organizations scale, evolve, and translate strategy into execution. As CEO, she will lead IDDI’s strategy and operations, building on the company’s 35-year heritage pioneering biostatistical innovation to continue advancing clinical data science.
Marc, who founded IDDI in 1991, will continue as Chief Scientific Officer and remain closely involved in shaping IDDI’s strategy and fostering scientific excellence across the organization. In this role, he will continue to provide scientific leadership and help advance the innovative statistical and methodological approaches that underpin IDDI’s work.
“IDDI has something truly distinctive: a rare combination of deep medical understanding, biostatistical excellence, and regulatory insight that allows us to go beyond execution and bring real scientific intelligence to clinical development,” said Maud. “Our ambition is to build on that exceptional foundation, while continuing to evolve how we combine science, data, and technology. I’m excited to lead IDDI alongside Marc and our exceptionally talented team.”
As part of the leadership changes, Tara Kervin, MPH, has been appointed Chief Strategy Officer alongside her position as Managing Director, U.S. Tara will take a broader role in shaping and executing IDDI’s strategy, helping ensure the company’s scientific expertise and capabilities continue to disrupt clinical research and respond to evolving industry and customer needs.
Judith De Kempeneer has been appointed Vice President of Customer Experience. She will lead IDDI’s Technology Services, Project Management, and Business Services teams, with a focus on strengthening customer partnership, delivery excellence, and consistency across the customer journey.
Together, the changes bring greater focus to IDDI’s scientific leadership, strategy, and customer experience as the company continues its commitment to advancing clinical data science and helping sponsors generate the evidence needed to make better decisions throughout clinical development.
About IDDI
IDDI is a trusted clinical data science partner. With 35+ years of research-driven experience, we combine therapeutic expertise, biostatistical leadership, and regulatory insight to mitigate risk from design to registration and beyond. We deliver uncompromising excellence in biostatistics, strategic consulting, clinical data management, IDMCs, and supporting eClinical technologies, because when every data point represents a patient, perfection is the only option.
